NewcelX (NCEL) Enterprise Value (2019 - 2025)
NewcelX (NCEL) posted quarterly Enterprise Value of -$2.2 million for Q4 2025, down 238.62% year-over-year from $1.6 million in Q4 2024, and down 636.12% quarter-over-quarter from -$299000.0 in Q2 2025.
NewcelX (NCEL) Enterprise Value (2019 - 2025) Analysis & Trends
NewcelX (NCEL) has reported Enterprise Value for 7 consecutive years, with -$2.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value fell 238.62% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at -$2.2 million (down 238.62% YoY), while the FY2025 annual figure was -$2.2 million, down 238.62% from the prior year.
- Enterprise Value eased to -$2.2 million in Q4 2025 per NCEL's latest filing, from -$299000.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$299000.0 in Q2 2025 and bottomed at -$7.1 million in Q2 2021.
- Historically, Enterprise Value has averaged -$2.2 million across 5 years, with a median of -$1.3 million in 2022.
- Annual changes were most pronounced in 2021 — Enterprise Value slumped 5695.69% — and 2022, when it surged 80.91%.
- NewcelX's Enterprise Value stood at -$5.4 million in 2021, then jumped by 66.56% to -$1.8 million in 2022, then jumped by 36.89% to -$1.1 million in 2023, then soared by 43.28% to -$650000.0 in 2024, then slumped by 238.62% to -$2.2 million in 2025.
- Business Quant data shows NCEL's Enterprise Value at -$2.2 million in Q4 2025, -$299000.0 in Q2 2025, and -$650000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.12 Bn |
| 10 | NewcelX | 12.54 Mn | 10.34 Mn | - | -2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.20 Mn |
| Jun 30, 2025 | -299,000.00 |
| Dec 31, 2024 | -650,000.00 |
| Jun 30, 2024 | -548,000.00 |
| Dec 31, 2023 | -1.15 Mn |
| Jun 30, 2023 | -1.13 Mn |
| Dec 31, 2022 | -1.82 Mn |
| Jun 30, 2022 | -1.35 Mn |
| Dec 31, 2021 | -5.43 Mn |
| Jun 30, 2021 | -7.09 Mn |
| Dec 31, 2020 | -93,711.00 |
| Dec 31, 2019 | -220,267.00 |